Novavax(NVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NVAX Novavax

Not Yet Opened 06-11 16:00:00 EDT

9.03

+0.47

+5.49%

盘后9.01

-0.02-0.25%

19:59 EDT

High9.09	Low8.45	Vol3.57M
Open8.54	D1 Closing8.56	Amplitude7.48%
Mkt Cap1.48B	Tradable Cap1.23B	Total Shares164.43M
T/O31.59M	T/O Rate2.61%	Tradable Shares136.72M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NVAX","market":"US","secType":"STK","nameCN":"Novavax","latestPrice":9.03,"timestamp":1781208000000,"preClose":8.56,"halted":0,"volume":3573358,"hourTrading":{"tag":"盘后","latestPrice":9.007,"preClose":9.03,"latestTime":"19:59 EDT","volume":42908,"amount":386163.7715,"timestamp":1781222372838,"change":-0.023,"changeRate":-0.002547,"amplitude":0.023256},"delay":0,"changeRate":0.054906542056074634,"floatShares":136723812,"shares":164427429,"eps":-0.5784,"marketStatus":"Not Yet Opened","change":0.47,"latestTime":"06-11 16:00:00 EDT","open":8.54,"high":9.09,"low":8.45,"amount":31590914.60344,"amplitude":0.074766,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.5784,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781251200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":8.56,"preHourTrading":{"tag":"盘前","latestPrice":8.52,"preClose":8.56,"latestTime":"09:29 EDT","volume":14084,"amount":121188.13002799999,"timestamp":1781184556075,"change":-0.04,"changeRate":-0.004673,"amplitude":0.022196},"postHourTrading":{"tag":"盘后","latestPrice":9.007,"preClose":9.03,"latestTime":"19:59 EDT","volume":42908,"amount":386163.7715,"timestamp":1781222372838,"change":-0.023,"changeRate":-0.002547,"amplitude":0.023256},"volumeRatio":0.732689,"impliedVol":0.8487,"impliedVolPercentile":0.502},"requestUrl":"/m/hq/s/NVAX/wiki","defaultTab":"wiki","newsList":[{"id":"2642232109","title":"Novavax Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2642232109","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642232109?lang=en_us&edition=fundamental","pubTime":"2026-06-12 05:29","pubTimestamp":1781213340,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  rose 5.49% to $9.03 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 2.54% to 25,809.66 and the Dow Jones Industrial Average  rising 1.86% to 50,848.75.Novavax Inc. closed 24.56% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  fell 0.07% to $238.33, Pfizer Inc.  rose 2.23% to $26.17, and Merck & Co. Inc.  rose 1.40% to $120.76.Trading volume  remained 1.2 million below its 50-day average volume of 4.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NVAX","BK4585","BK4547","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642479411","title":"Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642479411","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642479411?lang=en_us&edition=fundamental","pubTime":"2026-06-11 05:28","pubTimestamp":1781126880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 1.27% to $8.56 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.98% to 25,169.50 and Dow Jones Industrial Average  falling 1.87% to 49,918.78.Novavax Inc. closed 28.49% below its 52-week high of $11.97, which the company achieved on February 26th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 0.63% to $238.49, Pfizer Inc.  fell 0.39% to $25.60, and Merck & Co. Inc.  fell 0.43% to $119.09.Trading volume  remained 1.7 million below its 50-day average volume of 4.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 10, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4588","BK4547","NVAX","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642243171","title":"Novavax Inc. Stock Sheds 9.2%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2642243171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642243171?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:33","pubTimestamp":1780950780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Novavax Inc. slipped 9.2% to $8.62 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.9% to 25,929.66 and the Dow Jones Industrial Average falling 0.2% to 50,786.01.This was the stock's sixth consecutive day of losses.Novavax Inc. closed 28.0% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.3% to $232.16, Pfizer Inc. fell 1.6% to $25.62, and Merck & Co. Inc. fell 1.05% to $119.52.Trading volume totaled 6.8 million, compared to the 50-day average of 4.7 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4547","NVAX","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641128599","title":"Novavax Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641128599","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641128599?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:28","pubTimestamp":1780694880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 6.87% to $9.49 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 4.18% to 25,709.43 and Dow Jones Industrial Average  falling 1.35% to 50,866.78.This was the stock's fifth consecutive day of losses.Novavax Inc. closed 20.72% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 2.02% to $232.77, Pfizer Inc.  rose 1.36% to $26.04, and Merck & Co. Inc.  rose 0.44% to $120.79.Trading volume  remained 108,989 below its 50-day average volume of 4.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 5, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and T","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVY","BK4139","SDY","DJX","BK4568","NVAX","GRNY","VUG","TOPT","YMAX","SDOW","DGRW","MGK","BK4588","DOG","SCHD","BK4585","FDN",".DJI","DXD","MYMmain","BK4547","SCHG","VYMI","DGRO","DDM","FDVV","DIA","UDOW","XLI","VYM","DJIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641412591","title":"Novavax’s Combo COVID-19 and Flu Shot Trial Reaches Key Milestone for Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2641412591","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641412591?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:30","pubTimestamp":1780677025,"startTime":"0","endTime":"0","summary":"Novavax ($NVAX) announced an update on their ongoing clinical study. The study, titled “A Randomized, Observer-Blinded, Active-Controlled Study to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novavaxs-combo-covid-19-and-flu-shot-trial-reaches-key-milestone-for-older-adults?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novavaxs-combo-covid-19-and-flu-shot-trial-reaches-key-milestone-for-older-adults?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4588","BK4548","BK4547","BK4535","NVAX","BNTX","BK4551","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641314125","title":"Novavax and Sanofi Advance Omicron JN.1 Booster With Completed Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2641314125","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641314125?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:30","pubTimestamp":1780677011,"startTime":"0","endTime":"0","summary":"Novavax ($NVAX) announced an update on their ongoing clinical study. The Phase 3 study “A Phase 3 Open-Label, Single-Arm Study to Evaluate the Safe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novavax-and-sanofi-advance-omicron-jn-1-booster-with-completed-phase-3-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novavax-and-sanofi-advance-omicron-jn-1-booster-with-completed-phase-3-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4547","BK4568","BK4585","BK4588","BK4007","BK4139","NVAX","SNYNF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640676679","title":"Novavax Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640676679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640676679?lang=en_us&edition=fundamental","pubTime":"2026-06-02 05:28","pubTimestamp":1780349280,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 4.19% to $10.51 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.42% to 27,086.81 and the Dow Jones Industrial Average  rising 0.09% to 51,078.88.Novavax Inc. closed 12.20% below its 52-week high of $11.97, which the company reached on February 26th.The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson  fell 0.81% to $223.51, Pfizer Inc.  fell 2.10% to $25.63, and Merck & Co. Inc.  fell 2.99% to $115.17.Trading volume  remained 10,749 below its 50-day average volume of 4.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 1, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4588","NVAX","BK4568","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640696107","title":"Novavax to present at Jefferies Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2640696107","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640696107?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:00","pubTimestamp":1780344039,"startTime":"0","endTime":"0","summary":"Novavax will participate in the 2026 Jefferies Global Healthcare Conference in New York on June 4, 2026.Management is scheduled for a fireside chat from 10:30 a.m. to 11:00 a.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL8YzTX0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4139","BK4588","NVAX","BK4568","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639467769","title":"Novavax Inc. Stock Rallies 6.3%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2639467769","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639467769?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:34","pubTimestamp":1780086840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Novavax Inc. advanced 6.3% to $10.97 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,972.62 and the Dow Jones Industrial Average rising 0.7% to 51,032.46.Novavax Inc. closed 8.4% short of its 52-week high of $11.97, which the company reached on February 26th.The stock outperformed some of its peers, as Johnson & Johnson fell 2.4% to $225.33, Pfizer Inc. rose 0.2% to $26.18, and Merck & Co. Inc. fell 0.98% to $118.72.Trading volume totaled 7.1 million, compared to the 50-day average of 4.6 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4139","BK4568","BK4547","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639618234","title":"US FDA Advisers Vote in Favor of Recommending Covid Vaccines Target Jn.1 Lineage Xfg Variant for 2026-27 Campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2639618234","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639618234?lang=en_us&edition=fundamental","pubTime":"2026-05-29 02:26","pubTimestamp":1779992787,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nFWN4250W6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1894683264.USD","SG9999001176.USD","MRNX","LU1023059063.AUD","IE00BLSP4239.USD","LU0306806265.USD","LU0321505868.SGD","LU0985481810.HKD","LU0868494617.USD","SG9999003800.SGD","BK4551","LU0058720904.USD","PFE","LU0456855351.SGD","SG9999011175.SGD","BK4532","BK4592","BK4581","BK4599","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU1066053197.SGD","BK4501","LU0170899867.USD","SG9999002232.USD","MRNA","BK4533","LU1057294990.SGD","MRNY","LU0306807586.USD","IE00B19Z3B42.SGD","BK4534","LU1883839398.USD","IE0002270589.USD","BK4548","BK4588","SG9999001176.SGD","BK4547","BK4568","IE00B3T34201.USD","LU0122379950.USD","NVAX","BK4139","LU1066051498.USD","BK4550","LU1894683348.USD","SG9999013999.USD","SG9999002224.SGD","LU0289739699.SGD","LU0225771236.USD","BK4007","LU0225284248.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0321505439.SGD","IE00B19Z3581.USD","BK4585","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199656658","title":"Stock Track | Novavax Plummets 5.04% Intraday on FDA Vaccine Composition Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1199656658","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199656658?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:44","pubTimestamp":1779975862,"startTime":"0","endTime":"0","summary":"Novavax's stock plummeted 5.04% during intraday trading on Thursday, as investors reacted to regulatory uncertainty surrounding the composition of COVID-19 vaccines for the upcoming season.The U.S....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638669353","title":"Sanofi Says Manufacturing Xfg Protein Nuvaxovid Vaccine as Its Single Global Covid-19 Product for the 2026-27 Season: Briefing Docs","url":"https://stock-news.laohu8.com/highlight/detail?id=2638669353","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638669353?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:19","pubTimestamp":1779970779,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nL4N425173:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4585","GCVRZ","BK4139","NVAX","BK4547","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638664846","title":"FDA advisers to weigh composition of COVID vaccines for 2026-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2638664846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638664846?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:00","pubTimestamp":1779962400,"startTime":"0","endTime":"0","summary":"FDA advisers to weigh composition of COVID vaccines for 2026-2027By Christy Santhosh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nL4N424142:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU0058720904.USD","LU0306806265.USD","LU1066053197.SGD","SG9999002232.USD","SGXZ57979304.SGD","SG9999003800.SGD","LU0225771236.USD","LU0225284248.USD","IE00B3T34201.USD","BK4501","LU1894683264.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4007","BK4581","LU1883839398.USD","IE00BLSP4452.SGD","LU0985481810.HKD","LU0321505439.SGD","BK4568","LU1057294990.SGD","SG9999001176.SGD","BK4548","MRNY","SG9999002224.SGD","SG9999011175.SGD","BK4592","BK4534","LU0456855351.SGD","BK4547","LU0289739699.SGD","LU0306807586.USD","LU0868494617.USD","LU1066051498.USD","BK4585","LU0170899867.USD","LU1894683348.USD","IE00BLSP4239.USD","LU1023059063.AUD","MRNX","BK4139","BK4551","SG9999001176.USD","SG9999013999.USD","LU0234572021.USD","BK4588","BK4533","BK4532","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0321505868.SGD","BK4550","BK4599","NVAX","PFE","MRNA","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638631348","title":"Novavax Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2638631348","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638631348?lang=en_us&edition=fundamental","pubTime":"2026-05-28 05:28","pubTimestamp":1779917280,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  rallied 6.02% to $11.09 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.07% to 26,674.73 and the Dow Jones Industrial Average  rising 0.36% to 50,644.28.This was the stock's third consecutive day of gains.Novavax Inc. closed 7.35% below its 52-week high of $11.97, which the company reached on February 26th.The stock outperformed some of its competitors Wednesday, as Johnson & Johnson  rose 0.48% to $231.29, Pfizer Inc.  rose 1.39% to $26.21, and Merck & Co. Inc.  rose 0.43% to $120.24.Trading volume  eclipsed its 50-day average volume of 4.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 27, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","NVAX","BK4585","BK4568","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638533528","title":"Novavax Inc. Stock Rallies 13.6%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2638533528","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638533528?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:33","pubTimestamp":1779827580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Novavax Inc. jumped 13.6% to $10.46 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.2% to 26,656.18 and the Dow Jones Industrial Average falling 0.2% to 50,461.68.This was the stock's second consecutive day of gains.Novavax Inc. closed 12.6% short of its 52-week high of $11.97, which the company reached on February 26th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.6% to $230.18, Pfizer Inc. fell 0.2% to $25.85, and Merck & Co. Inc. fell 2.20% to $119.72.Trading volume totaled 8.2 million, compared to the 50-day average of 4.4 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NVAX","BK4547","BK4568","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174175690","title":"Stock Track | Novavax Soars 12.54% as FDA Considers XFG-Targeted COVID Vaccine Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1174175690","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174175690?lang=en_us&edition=fundamental","pubTime":"2026-05-26 23:35","pubTimestamp":1779809715,"startTime":"0","endTime":"0","summary":"Novavax's stock surged 12.54% intraday on Tuesday as investors reacted to regulatory developments regarding COVID-19 vaccine formulations.The U.S. Food and Drug Administration's advisory committee is...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638954371","title":"US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant","url":"https://stock-news.laohu8.com/highlight/detail?id=2638954371","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638954371?lang=en_us&edition=fundamental","pubTime":"2026-05-26 22:52","pubTimestamp":1779807176,"startTime":"0","endTime":"0","summary":"US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant May 26 (Reuters) - Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be upd","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nL4N4230ZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","BK4588","BK4599","IE000M9KFDE8.USD","LU0306807586.USD","PFE","NVAX","LU0170899867.USD","BK4548","SG9999011175.SGD","MRNX","MRNA","BK4585","BK4139","IE00BLSP4239.USD","LU0225771236.USD","LU1057294990.SGD","LU0306806265.USD","BK4501","BK4534","IE00BBT3K403.USD","IE00B3T34201.USD","LU0985481810.HKD","MRNY","SG9999002232.USD","LU1894683264.USD","SG9999013999.USD","SGXZ57979304.SGD","LU0321505439.SGD","BK4547","BK4532","IE00BLSP4452.SGD","LU0234572021.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","BK4550","LU0868494617.USD","SG9999002224.SGD","IE00B19Z3581.USD","LU1023059063.AUD","BK4581","BK4551","BK4007","BK4533","LU1066053197.SGD","LU0321505868.SGD","LU0289739699.SGD","BK4568","LU0456855351.SGD","IE0002270589.USD","SG9999003800.SGD","SG9999001176.USD","BK4592","LU0225284248.USD","LU1883839398.USD","LU0122379950.USD","LU0058720904.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638536111","title":"The Bull Case For Novavax (NVAX) Could Change Following Shah Capital’s Activist Governance Challenge - Learn Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2638536111","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638536111?lang=en_us&edition=fundamental","pubTime":"2026-05-25 16:22","pubTimestamp":1779697354,"startTime":"0","endTime":"0","summary":"On May 15, 2026, Shah Capital Management disclosed that it had sent an “Elevating Novavax” presentation to Novavax’s board, criticizing leadership over marketing since 2023, the Sanofi partnership, capital markets decisions, and executive pay practices.\nThis intervention signals rising shareholder pressure around governance and capital allocation, potentially increasing expectations for management or board changes at Novavax.\nWith Shah Capital challenging Novavax’s leadership and partnership...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nvax/novavax/news/the-bull-case-for-novavax-nvax-could-change-following-shah-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nvax/novavax/news/the-bull-case-for-novavax-nvax-could-change-following-shah-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NVAX","BK4568","BK4588","BK4585","BK4547","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637321508","title":"Assessing Novavax (NVAX) Valuation As Shah Capital Challenges Leadership And Sanofi Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2637321508","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637321508?lang=en_us&edition=fundamental","pubTime":"2026-05-23 15:36","pubTimestamp":1779521782,"startTime":"0","endTime":"0","summary":"Activist pressure puts Novavax (NVAX) leadership under scrutiny\nShah Capital Management has challenged Novavax (NVAX) leadership in a detailed Elevating Novavax Presentation, criticizing marketing since 2023, the Sanofi partnership, capital market decisions, and executive conduct toward shareholder value.\nSee our latest analysis for Novavax.\nThe activist presentation lands after a period where momentum in Novavax’s share price has been mixed, with a 1-month share price return of 8.99% and a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nvax/novavax/news/assessing-novavax-nvax-valuation-as-shah-capital-challenges","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nvax/novavax/news/assessing-novavax-nvax-valuation-as-shah-capital-challenges","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NVAX","BK4585","BK4568","BK4007","BK4547","BK4139","SNYNF","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637450703","title":"Novavax Updates Pediatric COVID-19 Vaccine Trial: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2637450703","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637450703?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:30","pubTimestamp":1779467436,"startTime":"0","endTime":"0","summary":"Novavax ($NVAX) announced an update on their ongoing clinical study. Novavax (NVAX) is running a Phase 2/3 trial called “A Phase 2/3 Age De-escalat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novavax-updates-pediatric-covid-19-vaccine-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novavax-updates-pediatric-covid-19-vaccine-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4547","BK4588","BNTX","BK4568","BK4585","BK4211","NVAX","ISBC","BK4551","BK4535","BK4548"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novavax.com","stockEarnings":[{"period":"1week","weight":-0.1608},{"period":"1month","weight":-0.0989},{"period":"3month","weight":-0.1689},{"period":"6month","weight":0.3029},{"period":"1year","weight":0.1889},{"period":"ytd","weight":0.2738}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.114},{"period":"6month","weight":0.0821},{"period":"1year","weight":0.2268},{"period":"ytd","weight":0.0819}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.","yearOnYearQuotes":[{"month":1,"riseRate":0.677419,"avgChangeRate":0.108114},{"month":2,"riseRate":0.580645,"avgChangeRate":0.042802},{"month":3,"riseRate":0.258065,"avgChangeRate":-0.045948},{"month":4,"riseRate":0.451613,"avgChangeRate":0.007887},{"month":5,"riseRate":0.548387,"avgChangeRate":0.134336},{"month":6,"riseRate":0.483871,"avgChangeRate":0.080366},{"month":7,"riseRate":0.566667,"avgChangeRate":0.019422},{"month":8,"riseRate":0.533333,"avgChangeRate":0.039885},{"month":9,"riseRate":0.5,"avgChangeRate":-0.036425},{"month":10,"riseRate":0.3,"avgChangeRate":0.027361},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.003351},{"month":12,"riseRate":0.366667,"avgChangeRate":-0.038609}],"exchange":"NASDAQ","name":"Novavax","nameEN":"Novavax"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Novavax(NVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Novavax(NVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Novavax,NVAX,Novavax股票,Novavax股票老虎,Novavax股票老虎国际,Novavax行情,Novavax股票行情,Novavax股价,Novavax股市,Novavax股票价格,Novavax股票交易,Novavax股票购买,Novavax股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Novavax(NVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Novavax(NVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction